Corticotherapy for traumatic brain-injured Patients - The Corti-TC trial: study protocol for a randomized controlled trial
Open Access
- 14 October 2011
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 12 (1) , 228
Abstract
Traumatic brain injury (TBI) is a main cause of severe prolonged disability of young patients. Hospital acquired pneumonia (HAP) add to the morbidity and mortality of traumatic brain-injured patients. In one study, hydrocortisone for treatment of traumatic-induced corticosteroid insufficiency (CI) in multiple injured patients has prevented HAP, particularly in the sub-group of patients with severe TBI. Fludrocortisone is recommended in severe brain-injured patients suffering from acute subarachnoid hemorrhage. Whether an association of hydrocortisone with fludrocortisone protects from HAP and improves neurological recovery is uncertain. The aim of the current study is to compare corticotherapy to placebo for TBI patients with CI.Keywords
This publication has 34 references indexed in Scilit:
- Management and outcome of mechanically ventilated neurologic patients*Critical Care Medicine, 2011
- Mechanism, Glasgow Coma Scale, Age, and Arterial Pressure (MGAP): A new simple prehospital triage score to predict mortality in trauma patients*Critical Care Medicine, 2010
- Intensive versus Conventional Glucose Control in Critically Ill PatientsNew England Journal of Medicine, 2009
- The paradox of ventilator-associated pneumonia prevention measuresCritical Care, 2009
- AcknowledgmentsJournal of Neurotrauma, 2007
- Intensive Insulin Therapy in the Medical ICUNew England Journal of Medicine, 2006
- Impact of Ventilator-Associated Pneumonia in Patients with Severe Head Injury2004
- Early Onset PneumoniaAnesthesiology, 2004
- Cortisol Response to Corticotropin Stimulation in Trauma PatientsAnesthesiology, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999